Ester derivatives as phosphodiesterase inhibitors

Details Ester derivatives as phosphodiesterase inhibitors Ester derivatives as phosphodiesterase inhibitors

2011-06-28

2011-06-28

Andres, Janet L (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S337000

Reexamination Certificate

active

07968724

ABSTRACT:
The invention provides inhibitors of the phosphodiesterase 4 (PDE4) enzyme. More particularly, the invention relates to compounds that are new ester derivatives, methods of preparing such compounds, compositions containing them, and therapeutic uses thereof.

REFERENCES:
patent: 2008/0015226 (2008-01-01), Amari et al.
patent: 94-02465 (1994-02-01), None
patent: 95-35281 (1995-12-01), None
patent: 2006-064355 (2006-06-01), None
Buist, A. S., “Similarities and Differences between Asthma and Chronic Obstructive Pulmonary Disease: Treatment and Early Outcomes”, Eur. Respir. J. 2003; 21: Suppl. 39, pp. 30s-35s.
U.S. Appl. No. 12/188,631, filed Aug. 8, 2008, Delcanale, et al.
Jacobitz, S. et al.,Molecular Pharmacology., 1996, 50, 891-899.
Giembycz, M.A. et al.,Expert Opin. Investg. Drugs., 2001; 10:1361-1379.
U.S. Appl. No. 12/700,926, filed Feb. 5, 2010, Amari, et al.

Affiliated with

Also associated with

Rating

Ester derivatives as phosphodiesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ester derivatives as phosphodiesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ester derivatives as phosphodiesterase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2686381